GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Scaled Net Operating Assets

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Scaled Net Operating Assets : 0.86 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tonghua Golden-horse Pharmaceutical Industry Co's operating assets for the quarter that ended in Mar. 2024 was ¥4,359 Mil. Tonghua Golden-horse Pharmaceutical Industry Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥475 Mil. Tonghua Golden-horse Pharmaceutical Industry Co's Total Assets for the quarter that ended in Dec. 2023 was ¥4,519 Mil. Therefore, Tonghua Golden-horse Pharmaceutical Industry Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.86.


Tonghua Golden-horse Pharmaceutical Industry Co Scaled Net Operating Assets Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Scaled Net Operating Assets Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.83 0.78 0.83 0.82

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.85 0.85 0.86 0.86

Competitive Comparison of Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets falls into.



Tonghua Golden-horse Pharmaceutical Industry Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(4340.749-498.58)/4685.115
=0.82

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4519.244 - 178.495
=4340.749

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2201.117 - 1559.511 - 143.026
=498.58

Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(4359.395-474.895)/4519.244
=0.86

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4605.021 - 245.626
=4359.395

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2277.728 - 1569.007 - 233.826
=474.895

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonghua Golden-horse Pharmaceutical Industry Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines